Logo image of MNDY

MONDAY.COM LTD (MNDY) Stock Fundamental Analysis

NASDAQ:MNDY - Nasdaq - IL0011762130 - Common Stock - Currency: USD

250  -14.92 (-5.63%)

After market: 250 0 (0%)

Fundamental Rating

5

Overall MNDY gets a fundamental rating of 5 out of 10. We evaluated MNDY against 286 industry peers in the Software industry. While MNDY has a great health rating, there are worries on its profitability. MNDY is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MNDY had positive earnings in the past year.
MNDY had a positive operating cash flow in the past year.
In the past 5 years MNDY always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: MNDY reported negative operating cash flow in multiple years.
MNDY Yearly Net Income VS EBIT VS OCF VS FCFMNDY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

The Return On Assets of MNDY (1.37%) is better than 65.59% of its industry peers.
MNDY has a Return On Equity of 2.23%. This is in the better half of the industry: MNDY outperforms 67.03% of its industry peers.
Industry RankSector Rank
ROA 1.37%
ROE 2.23%
ROIC N/A
ROA(3y)-9.35%
ROA(5y)-38.64%
ROE(3y)-13.31%
ROE(5y)-243.3%
ROIC(3y)N/A
ROIC(5y)N/A
MNDY Yearly ROA, ROE, ROICMNDY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -200 -400 -600 -800 -1K

1.3 Margins

With a decent Profit Margin value of 2.39%, MNDY is doing good in the industry, outperforming 65.59% of the companies in the same industry.
MNDY's Gross Margin of 89.46% is amongst the best of the industry. MNDY outperforms 96.77% of its industry peers.
MNDY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 2.39%
GM 89.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.12%
GM growth 5YN/A
MNDY Yearly Profit, Operating, Gross MarginsMNDY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50 -100

8

2. Health

2.1 Basic Checks

MNDY does not have a ROIC to compare to the WACC, probably because it is not profitable.
MNDY has more shares outstanding than it did 1 year ago.
There is no outstanding debt for MNDY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MNDY Yearly Shares OutstandingMNDY Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 10M 20M 30M 40M
MNDY Yearly Total Debt VS Total AssetsMNDY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

MNDY has an Altman-Z score of 13.61. This indicates that MNDY is financially healthy and has little risk of bankruptcy at the moment.
MNDY's Altman-Z score of 13.61 is amongst the best of the industry. MNDY outperforms 88.17% of its industry peers.
There is no outstanding debt for MNDY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 13.61
ROIC/WACCN/A
WACC9.11%
MNDY Yearly LT Debt VS Equity VS FCFMNDY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 2.67 indicates that MNDY has no problem at all paying its short term obligations.
MNDY has a Current ratio of 2.67. This is in the better half of the industry: MNDY outperforms 72.40% of its industry peers.
MNDY has a Quick Ratio of 2.67. This indicates that MNDY is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MNDY (2.67) is better than 72.76% of its industry peers.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.67
MNDY Yearly Current Assets VS Current LiabilitesMNDY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 87.12% over the past year.
Looking at the last year, MNDY shows a very strong growth in Revenue. The Revenue has grown by 33.90%.
MNDY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 65.46% yearly.
EPS 1Y (TTM)87.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.81%
Revenue 1Y (TTM)33.9%
Revenue growth 3Y65.46%
Revenue growth 5YN/A
Sales Q2Q%32.67%

3.2 Future

Based on estimates for the next years, MNDY will show a very strong growth in Earnings Per Share. The EPS will grow by 34.85% on average per year.
MNDY is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.06% yearly.
EPS Next Y77.74%
EPS Next 2Y43.15%
EPS Next 3Y37.39%
EPS Next 5Y34.85%
Revenue Next Year33.19%
Revenue Next 2Y29.75%
Revenue Next 3Y28.05%
Revenue Next 5Y27.06%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MNDY Yearly Revenue VS EstimatesMNDY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B 5B
MNDY Yearly EPS VS EstimatesMNDY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 10 15 20

4

4. Valuation

4.1 Price/Earnings Ratio

MNDY is valuated quite expensively with a Price/Earnings ratio of 81.97.
MNDY's Price/Earnings is on the same level as the industry average.
MNDY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.28.
MNDY is valuated quite expensively with a Price/Forward Earnings ratio of 66.30.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MNDY is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 91.29. MNDY is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 81.97
Fwd PE 66.3
MNDY Price Earnings VS Forward Price EarningsMNDY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MNDY is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 44.81
EV/EBITDA N/A
MNDY Per share dataMNDY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

MNDY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
MNDY's earnings are expected to grow with 37.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.05
PEG (5Y)N/A
EPS Next 2Y43.15%
EPS Next 3Y37.39%

0

5. Dividend

5.1 Amount

MNDY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MONDAY.COM LTD

NASDAQ:MNDY (1/29/2025, 8:00:00 PM)

After market: 250 0 (0%)

250

-14.92 (-5.63%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-11 2024-11-11/bmo
Earnings (Next)02-10 2025-02-10/amc
Inst Owners80.87%
Inst Owner Change1.22%
Ins Owners16.43%
Ins Owner ChangeN/A
Market Cap12.48B
Analysts80.67
Price Target328.46 (31.38%)
Short Float %7.2%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.74%
Min EPS beat(2)31.58%
Max EPS beat(2)63.89%
EPS beat(4)4
Avg EPS beat(4)59.88%
Min EPS beat(4)31.58%
Max EPS beat(4)96.12%
EPS beat(8)8
Avg EPS beat(8)119.18%
EPS beat(12)12
Avg EPS beat(12)98.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.59%
Min Revenue beat(2)-0.01%
Max Revenue beat(2)1.19%
Revenue beat(4)3
Avg Revenue beat(4)0.64%
Min Revenue beat(4)-0.01%
Max Revenue beat(4)1.19%
Revenue beat(8)7
Avg Revenue beat(8)1.52%
Revenue beat(12)11
Avg Revenue beat(12)2.46%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.72%
PT rev (3m)8.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)37.78%
EPS NY rev (1m)0%
EPS NY rev (3m)12.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.96%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.58%
Valuation
Industry RankSector Rank
PE 81.97
Fwd PE 66.3
P/S 13.77
P/FCF 44.81
P/OCF 42.62
P/B 12.85
P/tB 12.85
EV/EBITDA N/A
EPS(TTM)3.05
EY1.22%
EPS(NY)3.77
Fwd EY1.51%
FCF(TTM)5.58
FCFY2.23%
OCF(TTM)5.87
OCFY2.35%
SpS18.16
BVpS19.45
TBVpS19.45
PEG (NY)1.05
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.37%
ROE 2.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.39%
GM 89.46%
FCFM 30.73%
ROA(3y)-9.35%
ROA(5y)-38.64%
ROE(3y)-13.31%
ROE(5y)-243.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.12%
GM growth 5YN/A
F-Score7
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 127.47%
Cap/Sales 1.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 1283.49%
Current Ratio 2.67
Quick Ratio 2.67
Altman-Z 13.61
F-Score7
WACC9.11%
ROIC/WACCN/A
Cap/Depr(3y)279.33%
Cap/Depr(5y)286.62%
Cap/Sales(3y)3.19%
Cap/Sales(5y)3.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.81%
EPS Next Y77.74%
EPS Next 2Y43.15%
EPS Next 3Y37.39%
EPS Next 5Y34.85%
Revenue 1Y (TTM)33.9%
Revenue growth 3Y65.46%
Revenue growth 5YN/A
Sales Q2Q%32.67%
Revenue Next Year33.19%
Revenue Next 2Y29.75%
Revenue Next 3Y28.05%
Revenue Next 5Y27.06%
EBIT growth 1Y33.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year172.97%
EBIT Next 3Y67.25%
EBIT Next 5Y55.44%
FCF growth 1Y2539.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4355.53%
OCF growth 3YN/A
OCF growth 5YN/A